CJC-1295 without DAC – Short-Acting GHRH Analogue Research Peptide
CJC-1295 without DAC is a synthetic Growth Hormone–Releasing Hormone (GHRH) analogue
designed to stimulate the release of growth hormone (GH) via the GHRH receptor.
Unlike the DAC-modified variant, this peptide has a shorter half-life, allowing researchers
to study the acute and physiological pulsatile secretion of growth hormone
under in-vitro conditions.
CJC-1295 without DAC is manufactured according to high laboratory standards and verified using
High-Performance Liquid Chromatography (HPLC) to ensure a purity of
≥ 99%. The product is supplied exclusively for controlled
endocrinological and biochemical research applications.
Key specifications
| Specification | Value / description |
|---|---|
| Name | CJC-1295 without DAC |
| Molecular formula | C152H252N44O42 |
| Molecular weight | ≈ 3368.9 Da |
| Form | Lyophilized powder |
| Purity | ≥ 99% (HPLC tested) |
| Storage conditions | Store refrigerated, protected from light and moisture |
Application & use (research only)
- Intended exclusively for in-vitro research purposes.
- Not suitable for human or veterinary consumption or medical use.
- Applicable to endocrinological and biochemical research on growth hormone regulation and receptor activation.
- Lyophilized form supports stable storage and controlled laboratory handling.
